The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy | Nature Communications
商品説明・詳細
送料・お届け
商品情報
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy | Nature Communications,Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis - Kidney International,CT26 Syngeneic Mouse Model - Altogen Labs,Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment,Anti-mouse CD8 | YTS 169.4-derived | InvivoGen